Skip to content
← Back to this collection

PUBLICATIONS · 12176872

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2002 Sep 1
First author
Saunthararajah Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Saunthararajah Y
      type
      Author
    2. name
      Nakamura R
      type
      Author
    3. name
      Nam JM
      type
      Author
    4. name
      Robyn J
      type
      Author
    5. name
      Loberiza F
      type
      Author
    6. name
      Maciejewski JP
      type
      Author
    7. name
      Simonis T
      type
      Author
    8. name
      Molldrem J
      type
      Author
    9. name
      Young NS
      type
      Author
    10. name
      Barrett AJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Saunthararajah Y
      type
      Author
    2. name
      Nakamura R
      type
      Author
    3. name
      Nam JM
      type
      Author
    4. name
      Robyn J
      type
      Author
    5. name
      Loberiza F
      type
      Author
    6. name
      Maciejewski JP
      type
      Author
    7. name
      Simonis T
      type
      Author
    8. name
      Molldrem J
      type
      Author
    9. name
      Young NS
      type
      Author
    10. name
      Barrett AJ
      type
      Author
    bibliography ids
    1. nci-bib-c3da96e0e29795b2a0d07c54
    book metadata
    content sha256
    737eab9a3242d977272d03fedf33af592f8f8047d9f24b25f5e26ed0c6c424c8
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:12176872
      immutable id
      pubmed:12176872@737eab9a3242d977272d03fedf33af592f8f8047d9f24b25f5e26ed0c6c424c8
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      5
      name
      Blood
      nlm unique id
      7603509
      pages
      1570-4
      volume
      100
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        12176872
        provenance
        batch id
        ced7794d3512d3f45188
        provider
        NCBI PubMed ESummary
        record sha256
        9daf2deedf69cbb78c7a3cafc291e01f76e5d1b249a155eab4be4d8ae3af77b1
        response sha256
        782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
        retrieved at
        2026-09-09T23:45:46.208577+00:00
        publication date
        display
        2002 Sep 1
        precision
        day
        year
        2002
        publication types
        1. Journal Article
        2. Multicenter Study
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/12176872/
        title
        HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

        Preserved source evidence · Not medical advice